Type 2 Diabetes with Chronic Kidney Disease Study
Type 2 Diabetes with Chronic Kidney Disease Trials in Phoenix
Centricity Research is currently participating in a chronic kidney disease study at our Phoenix, AZ location to test the safety and effectiveness of an investigational drug. Diabetic nephropathy is the kidney disease that occurs as a result of diabetes and is a serious kidney-related complication of type 1 diabetes and type 2 diabetes. It is also called diabetic kidney disease. About 25% of people with diabetes eventually develop kidney disease. Diabetic nephropathy affects your kidneys’ ability to do their usual work of removing waste products and extra fluid from your body. Advances in drug therapy are key to treating this disease at its early stages and preventing further damage.
Type 2 Diabetes with Chronic Kidney Disease Clinical Trial
The objective of this study is to assess whether 1800 mg once daily Metformin DR, an investigational drug, compared to placebo improves HbA1c after 28 weeks of treatment in patients with T2DM with varying renal function. You maybe be eligible to participate in this study if you are:
- At least 25 years old
- Have a BMI 20.0 to 45.0 kg/m2
- Have T2DM
Ready to Volunteer?
Call today to see if you qualify for our type 2 diabetes with chronic kidney disease study. Qualified volunteers may be compensated for time and travel.